Development and implementation of a patient reported experience measurement program to transform cancer care. This is an ASCO Meeting Abstract from the 2023 ASCO Quality Care Symposium. This abstract ...
Impact of the COVID-19 pandemic on neoadjuvant endocrine therapy utilization for stage I-III HR+/HER2- breast cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Quality Care Symposium. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results